Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone mouthwash for prevention of radiotherapy-induced oral mucositis in head and neck cancer
IRCT20240525061893N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stomatitis comparing Dexamethasone mouthwash with Placebo (2 arms). Primary endpoints: Prevention of mucositis during radiotherapy and Treatment completion without interruption. Started Mar 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20240525061893N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240525061893N1.